Clinical Trial

Home Exercise for Individuals with Neurodegenerative Disease

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 10, 2025 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The primary goal of this study is to address the need for targeted therapeutic interventions for impairments that impact walking in related neurodegenerative diseases.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-07-01; most recent amendment 2025-03-06.
Status change: Not Yet Recruiting → Recruiting 2022-11-07
Trial Details
NCT Number NCT05443906
Lead Sponsor Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Conditions Neurodegenerative Diseases, Leukodystrophy, Ataxia, LBSL, Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and High Lactate Syndrome (Disorder), Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation, Cerebellar Ataxia, Adrenomyeloneuropathy
Enrollment 30 participants
Start Date 2023-02-13
Primary Completion 2026-07-30 (estimated)
Study Completion 2027-07-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-10